Is MAP1A p.Asn233Ser (c.698A>G) pathogenic?

MAP1A p.Asn233Ser (c.698A>G) is classified Uncertain significance in MAP1A (ClinVar, Single submitter, 1 submitter; last evaluated 2024-11-10). AlphaMissense: likely benign (0.0441); Ultra-rare (popmax 0.098%, eas).

How common is MAP1A p.Asn233Ser (c.698A>G) in the general population?

MAP1A p.Asn233Ser (c.698A>G) is ultra-rare (popmax 0.098%, eas) (gnomAD).

What do computational predictors say about MAP1A p.Asn233Ser (c.698A>G)?

AlphaMissense predicts likely benign (score 0.0441) — an in-silico prediction, not a clinical call.

MAP1A p.Asn233Ser

c.698A>G · VCV3542568

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0441 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.098%, eas)

Missense predictors

0/2 damaging

AlphaMissense, REVEL · SaProt no call

Computational evidence

Protein change
AlphaMissense	0.0441	likely benign
REVEL	0.096	moderately benign-leaning
SaProt	—	not scored · why
⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 1.4	GERP -0.26, phastCons 0.094
Overall
CADD	17.65	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.098% East Asian · 44/44,898 alleles

Filtering AF 0.075% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0668%

Overall 0.00756% 122/1,614,134 alleles · ultra-rare exomes 114/1,461,892 · genomes 8/152,242 · joint denominator

Ancestry group	Frequency	1 in
East Asiangrpmax	0.098%	1,020
South Asian	0.0461%	2,169
Middle Eastern	0.0164%	6,084
Remaining individualsnot grpmax-eligible	0.008%	12,498
African / African-American	0.00667%	14,989
European (non-Finnish)	0.00203%	49,169
Admixed American	0.00167%	60,010

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: MAP1A
Protein: p.Asn233Ser
Coding: c.698A>G
MANE Select: NM_002373
Type: single nucleotide variant
Location: chr15:43522171 (GRCh38)
Structure: AlphaFold pLDDT 94.44 · 41 PDB
Residue 233: a β-strand

Full MAP1A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

MAP1A p.Arg2734Gln Uncertain significance ★★ same type
MAP1A p.Gly567Ala Uncertain significance ★★ ⚠ same type
MAP1A p.Gly482= Benign/Likely benign ★★ same type
MAP1A p.Leu1621Val Benign ★★ same type
MAP1A p.Ser1152= Likely benign ★★ same type
MAP1A p.Ser1311= Benign/Likely benign ★★ same type
MAP1A p.Ser1544= Benign ★★ same type
MAP1A p.Ser1858Cys Likely benign ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/map1a-p-asn233ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown